ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(17), P. 16993 - 17003
Published: Aug. 22, 2023
Effective
photodynamic
therapy
(PDT)
requires
photosensitizers
(PSs)
to
massively
generate
type
I
reactive
oxygen
species
(ROS)
in
a
less
oxygen-dependent
manner
the
hypoxia
tumor
microenvironment.
Herein,
we
present
cascade
strategy
boost
ROS,
especially
hydroxyl
radical
(OH·-),
generation
with
an
aggregation-induced
emission
(AIE)
photosensitizer-albumin
complex
for
hypoxia-tolerant
PDT.
The
cationic
AIE
PS
TPAQ-Py-PF6
(TPA
=
triphenylamine,
Q
anthraquinone,
Py
pyridine)
contains
three
important
moieties
cooperatively
enhance
free
generation:
AIE-active
TPA
unit
ensures
effective
triplet
exciton
aggregate,
anthraquinone
moiety
possesses
redox
cycling
ability
promote
electron
transfer,
while
methylpyridinium
cation
further
increases
intramolecular
charge
transfer
and
separation
processes.
Inserting
into
hydrophobic
domain
of
bovine
serum
albumin
nanoparticles
(BSA
NPs)
could
greatly
immobilize
its
molecular
geometry
increase
generation,
electron-rich
microenvironment
BSA
ultimately
leads
OH·-
generation.
Both
experimental
theoretical
results
confirm
effectiveness
our
cationization
immobilization
enhancing
In
vitro
vivo
experiments
validate
excellent
antitumor
PDT
performance
NPs,
superior
conventional
polymeric
encapsulation
approach.
Such
multidimensional
specially
boosting
shall
hold
great
potential
related
applications.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
33(48)
Published: Sept. 27, 2021
Photodynamic
therapy
(PDT)
has
aroused
great
research
interest
in
recent
years
owing
to
its
high
spatiotemporal
selectivity,
minimal
invasiveness,
and
low
systemic
toxicity.
However,
due
the
hypoxic
nature
characteristic
of
many
solid
tumors,
PDT
is
frequently
limited
therapeutic
effect.
Moreover,
consumption
O2
during
may
further
aggravate
tumor
condition,
which
promotes
proliferation,
metastasis,
invasion
resulting
poor
prognosis
treatment.
Therefore,
numerous
efforts
have
been
made
increase
content
with
goal
enhancing
efficacy.
Herein,
these
strategies
developed
past
decade
are
comprehensively
reviewed
alleviate
hypoxia,
including
1)
delivering
exogenous
directly,
2)
generating
situ,
3)
reducing
cellular
by
inhibiting
respiration,
4)
regulating
TME,
(e.g.,
normalizing
vasculature
or
disrupting
extracellular
matrix),
5)
hypoxia-inducible
factor
1
(HIF-1)
signaling
pathway
relieve
hypoxia.
Additionally,
-independent
Type-I
also
discussed
as
an
alternative
strategy.
By
reviewing
progress,
it
hoped
that
this
review
will
provide
innovative
perspectives
new
nanomaterials
designed
combat
hypoxia
avoid
associated
limitation
PDT.
Journal of the American Chemical Society,
Journal Year:
2023,
Volume and Issue:
145(7), P. 4081 - 4087
Published: Feb. 13, 2023
The
highly
oxygen-dependent
nature
of
photodynamic
therapy
(PDT)
limits
its
therapeutic
efficacy
against
hypoxic
solid
tumors
in
clinics,
which
is
an
urgent
problem
to
be
solved.
Herein,
we
develop
oxygen-independent
supramolecular
agent
that
produces
hydroxyl
radical
(•OH)
by
oxidizing
water
the
presence
intracellularly
abundant
pyruvic
acid
under
oxygen-free
conditions.
A
fluorene-substituted
BODIPY
was
designed
as
electron
donor
and
coassembled
with
perylene
diimide
acceptor
form
quadruple
hydrogen-bonded
agent.
Detailed
mechanism
studies
reveal
intermolecular
transfer
charge
separation
upon
light
irradiation
result
efficient
generation
ion
pairs.
Under
conditions,
cationic
radicals
directly
oxidize
generate
cytotoxic
•OH,
anionic
electrons
acid,
realizing
catalytic
cycle.
Thus,
this
exhibited
superb
photocytotoxicity
even
severe
environments
excellent
vivo
antitumor
on
HeLa-bearing
mouse
models.
This
work
provides
a
strategy
for
constructing
agents,
opens
up
avenue
effective
PDT
tumors.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
34(7)
Published: Dec. 22, 2021
Second
near-infrared
(NIR-II)
window
type-I
photosensitizers
have
intrinsic
advantages
in
photodynamic/photothermal
therapy
(PDT/PTT)
of
some
malignant
tumors
with
deep
infiltration,
large
size,
complicated
location,
and
low
possibility
surgery/radiotherapy.
Herein,
three
chalcogen-element-based
donor-acceptor-type
semiconducting
polymers
(poly[2,2″-((E)-4,4″-bis(2-octyldodecyl)-[6,6″-bithieno[3,2-b]pyrrolylidene]-5,5″(4H,4″H)-dione)-alt-2,5-(thiophene)]
(PTS),
poly[2,2″-((E)-4,4″-bis(2-octyldodecyl)-[6,6″-bithieno[3,2-b]pyrrolylidene]-5,5″(4H,4″H)-dione)-alt-2,5-(selenophene)]
(PTSe),
poly[2,2″-((E)-4,4″-bis(2-octyldodecyl)-[6,6″-bithieno[3,2-b]pyrrolylidene]-5,5″(4H,4'H)-dione)-alt-2,5-(tellurophene)]
(PTTe))
are
synthesized
fully
characterized,
demonstrating
strong
absorption
the
NIR-II
region.
Upon
adjusting
chalcogen
elements,
intramolecular
charge-transfer
characteristics
heavy-atom
effect
tuned
to
enhance
intersystem
crossing
rate,
improving
photodynamic
effect.
Moreover,
energy
levels
Gibbs
free
energies
facilitate
process.
As
a
result,
PTTe
nanoparticles
(NPs)
produce
superoxide
anion
radicals
(O2•-
)
more
efficiently
demonstrate
higher
photothermal
conversion
efficiency
than
PTS
PTSe
NPs
upon
(1064
nm)
laser
irradiation,
exhibiting
unprecedented
PDT/PTT
performance
vitro
vivo.
This
work
provides
ideas
for
achieving
high-performance
hypoxic
oncotherapy.
ACS Nano,
Journal Year:
2022,
Volume and Issue:
16(3), P. 4162 - 4174
Published: March 1, 2022
Tumor
hypoxia
seriously
impairs
the
therapeutic
outcomes
of
type
II
photodynamic
therapy
(PDT),
which
is
highly
dependent
upon
tissue
oxygen
concentration.
Herein,
a
facile
strategy
acceptor
planarization
and
donor
rotation
proposed
to
design
I
photosensitizers
(PSs)
photothermal
reagents.
Acceptor
can
not
only
enforce
intramolecular
charge
transfer
redshift
NIR
absorption
but
also
PSs
from
photochemical
pathways.
Donor
optimizes
conversion
efficiency
(PCE).
Accordingly,
three
3,6-divinyl-substituted
diketopyrrolopyrrole
(DPP)
derivatives,
2TPAVDPP,
TPATPEVDPP,
2TPEVDPP,
with
different
number
rotors
were
prepared.
Experimental
results
showed
that
compounds
excellent
PSs,
corresponding
2TPEVDPP
nanoparticles
(NPs)
most
possessed
highest
PCE.
The
photophysical
properties
NPs
are
particularly
suitable
for
in
vivo
fluorescence
imaging-guided
synergistic
PDT/PTT
therapy.
helpful
exploiting
phototherapeutic
reagents
high
efficacy
PDT
PTT.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: April 25, 2022
The
most
common
working
mechanism
of
photodynamic
therapy
is
based
on
high-toxicity
singlet
oxygen,
which
called
Type
II
therapy.
But
it
highly
dependent
oxygen
consumption.
Recently,
I
has
been
found
to
have
better
hypoxia
tolerance
ease
this
restriction.
However,
few
strategies
are
available
the
design
photosensitizers.
We
herein
report
an
unexpected
strategy
alleviate
limitation
traditional
by
biotinylation
three
photosensitizers
(two
fluorescein-based
and
commercially
Protoporphyrin).
biotiylated
named
as
compound
1,
2
3,
exhibit
impressive
ability
in
generating
both
superoxide
anion
radicals
oxygen.
Moreover,
1
can
be
activated
upon
low-power
white
light
irradiation
with
stronger
generation
than
other
two.
excellent
combinational
/
performance
demonstrated
1.
This
work
presents
a
universal
protocol
provide
tumor-targeting
enhance
or
trigger
against
tumor
hypoxia.
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
35(18)
Published: Nov. 18, 2022
Abstract
The
use
of
boron
dipyrromethene
(BODIPY)
in
biomedicine
is
reviewed.
To
open,
its
synthesis
and
regulatory
strategies
are
summarized,
inspiring
cutting‐edge
work
post‐functionalization
highlighted.
A
brief
overview
assembly
model
BODIPY
then
provided:
introduced
as
a
promising
building
block
for
the
formation
single‐
multicomponent
self‐assembled
systems,
including
nanostructures
suitable
aqueous
environments,
thereby
showing
great
development
potential
supramolecular
applications.
frontier
progress
biomedical
application
thereafter
described,
supported
by
examples
frontiers
applications
BODIPY‐containing
smart
materials:
it
mainly
involves
materials
based
on
blocks
their
assemblies
fluorescence
bioimaging,
photoacoustic
imaging,
disease
treatment
photodynamic
therapy,
photothermal
immunotherapy.
Lastly,
not
only
current
status
family
field
but
also
challenges
worth
considering
summarized.
At
same
time,
insights
into
future
prospects
biomedically
applicable
provided.
ACS Nano,
Journal Year:
2022,
Volume and Issue:
16(6), P. 9130 - 9141
Published: May 18, 2022
Photodynamic
therapy
as
an
emerging
phototheranostic
approach
holds
great
potential
for
antibacterial
treatment,
but
is
limited
by
compromised
reactive
oxygen
species
(ROS)
generation
in
aggregate
and
hypoxic
microenvironment.
Herein,
we
report
a
molecular
cationization
to
boost
the
ROS,
especially
type
I
ROS
of
aggregation-induced
emission
(AIE)
photosensitizers
photodynamic
treatment
drug-resistant
bacteria.
Such
reinforces
electron-accepting
ability
cationic
moiety,
promotes
intersystem
crossing
(ISC),
increases
electron
separation
transfer
processes.
The
resultant
CTBZPyI
exhibits
largely
enhanced
with
predominant
hydroxyl
radical
over
its
neutral
counterpart
aggregate.
Moreover,
also
confers
bacterial
binding
moderate
inactivation
dark.
Further
light
irradiation
leads
superb
performance,
which
healing
process
MRSA-infected
wound.
strategy
expected
be
general
design
highly
effective
infection
treatment.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(3), P. 585 - 585
Published: Jan. 18, 2023
Although
we
have
made
great
strides
in
treating
deadly
diseases
over
the
years,
cancer
therapy
still
remains
a
daunting
challenge.
Among
numerous
anticancer
methods,
photodynamic
(PDT),
non-invasive
therapeutic
approach,
has
attracted
much
attention.
PDT
exhibits
outstanding
performance
therapy,
but
some
unavoidable
disadvantages,
including
limited
light
penetration
depth,
poor
tumor
selectivity,
as
well
oxygen
dependence,
largely
limit
its
efficiency
for
solid
tumors
treatment.
Thus,
strategies
gone
into
overcoming
these
obstacles,
such
exploring
new
photosensitizers
with
higher
conversion
efficiency,
alleviating
hypoxia
to
fuel
generation
of
reactive
species
(ROS),
designing
tumor-targeted
PS,
and
applying
PDT-based
combination
strategies.
In
this
review,
briefly
summarized
related
approaches,
which
are
mainly
characterized
by
advanced
PSs,
PSs
excellent
additional
refreshing
features.
We
also
summarize
therapies
effects.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Oct. 19, 2022
Abstract
Given
that
Type-I
photosensitizers
(PSs)
have
hypoxia
tolerance,
developing
general
approaches
to
prepare
PSs
is
of
great
importance,
but
remains
a
challenge.
Here,
we
report
supramolecular
strategy
for
the
preparation
photodynamic
agents,
which
simultaneously
generate
strong
oxidizing
cationic
radicals
and
superoxide
radicals,
by
introducing
electron
acceptors
existing
Type-II
PSs.
As
proof-of-concept,
three
were
designed
co-assembled
with
classical
PS
produce
quadruple
hydrogen-bonded
agents.
The
photo-induced
transfer
from
adjacent
acceptor
occurs
efficiently,
leading
generation
+•
an
anionic
radical
acceptor,
further
transfers
oxygen
form
O
2
−•
.
In
addition,
these
agents
induce
direct
photocatalytic
oxidation
NADH
turnover
frequency
as
high
53.7
min
−1
,
offers
oxygen-independent
mechanism
damage
tumors.